3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
115
Gliosarcoma
53
Brain Neoplasms
53
Glioma
47
Central Nervous System Neoplasms
30
Astrocytoma
29
Melanoma
26
Oligodendroglioma
14
Neuroblastoma
10
Neoplasm Metastasis
9
Recurrence
7
Ependymoma
7
Sarcoma
6
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Skin Neoplasms
5
Sarcoma, Ewing
5
Lymphoma
5
Breast Neoplasms
5
Spinal Cord Neoplasms
4
Somatostatinoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Medulloblastoma
4
Colorectal Neoplasms
4
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Gastrinoma
3
Carcinoma, Islet Cell
3
Uveal Melanoma
2
Rhabdomyosarcoma
2
Interventions
Nivolumab
11
Ipilimumab
6
linrodostat
4
relatlimab
3
Pemetrexed
2
tislelizumab
1
regorafenib
1
ralimetinib
1
p38 Mitogen-Activated Protein Kinases
1
mirdametinib
1
gedatolisib
1
figitumumab
1
efatutazone
1
abemaciclib
1
Vorinostat
1
Tetanus Toxoid
1
Tamoxifen
1
Sunitinib
1
Ranitidine
1
Midazolam
1
LY2603618
1
LY2584702
1
Irinotecan
1
Gemcitabine
1
Fulvestrant
1
Dasatinib
1
Cyclophosphamide
1
Crizotinib
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Cancer
×
Temozolomide
×
Clear all
No trials found.